Skip to search formSkip to main contentSkip to account menu

dimethylargininase

Known as: dimethylarginine dimethylamidohydrolase, N(G),N(G)-dimethylarginine dimethylaminohydrolase, DADA-hydrolase 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Amidohydrolases

Narrower (2)

DDAH1 protein, humanDDAH2 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats
Abstract:  Nitric oxide (NO) deficiency is associated with development of hypertension. We examined whether melatonin protects… 
2010
2010
Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma.
Nitric oxide (NO), formed by nitric oxide synthase (NOS), is an important mediator of lung inflammation in allergic asthma… 
2010
2010
Overexpression of Dimethylarginine Dimethylaminohydrolase Protects Against Cerebral Vascular Effects of Hyperhomocysteinemia
Rationale: Hyperhomocysteinemia is a cardiovascular risk factor that is associated with elevation of the nitric oxide synthase… 
Highly Cited
2008
Highly Cited
2008
Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, has been proposed to be a mediator of… 
Highly Cited
2008
Highly Cited
2008
Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
BACKGROUND Decreased peritubular capillary (PTC) flow due to impaired endothelial function elicits tubulointerstitial ischaemia… 
2007
2007
Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH.
Review
2005
Review
2005
Asymmetric dimethylarginine (ADMA): the silent transition from an ‘uraemic toxin’ to a global cardiovascular risk molecule
Endothelial dysfunction as a result of reduced bioavailability of nitric oxide (NO) plays a central role in the process of… 
Highly Cited
2003
Highly Cited
2003
T he emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
There is abundant evidence that the endothelium plays a crucial role in the maintenance of vascular tone and structure. One of… 
2002
2002
Myocardial proteome analysis reveals reduced NOS inhibition and enhanced glycolytic capacity in areas of low local blood flow
In the heart, in situ local myocardial blood flow (MBF) varies greater than 10‐fold between individual areas and displays a… 
Highly Cited
1995
Highly Cited
1995
Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody.
Two endogenous inhibitors of nitric oxide synthesis, NG-monomethylarginine (MMA) and NG,NG-dimethylarginine (DMA), are broken… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)